INCIDENCE OF TREATMENT-ASSOCIATED IMAGING CHANGES IN NEWLY DIAGNOSED MGMT PROMOTER-METHYLATED GLIOBLASTOMA TREATED WITH CILENGITIDE (EORTC 26071-CENTRIC STUDY): INTERIM ANALYSIS

Flies, C. M.; Friedrich, M.; Lohmann, P.; van Garderen, K.; Smits, M.; Tonn, J. C.; Weller, M.; Galldiks, N.; Snijders, T. J.

doi:https://doi.org/10.1093/neuonc/noac174.327

INCIDENCE OF TREATMENT-ASSOCIATED IMAGING CHANGES IN NEWLY DIAGNOSED MGMT PROMOTER-METHYLATED GLIOBLASTOMA TREATED WITH CILENGITIDE (EORTC 26071-CENTRIC STUDY): INTERIM ANALYSIS

DSpace/Manakin Repository

INCIDENCE OF TREATMENT-ASSOCIATED IMAGING CHANGES IN NEWLY DIAGNOSED MGMT PROMOTER-METHYLATED GLIOBLASTOMA TREATED WITH CILENGITIDE (EORTC 26071-CENTRIC STUDY): INTERIM ANALYSIS

Flies, C. M.; Friedrich, M.; Lohmann, P.; van Garderen, K.; Smits, M.; Tonn, J. C.; Weller, M.; Galldiks, N.; Snijders, T. J.

(2022) Neuro-oncology, volume 24, pp.

(Abstract)

Download/Full Text

The full text of this publication is not available.

Version on publisher website for UU-students and staff

Version on publisher website

DOI: https://doi.org/10.1093/neuonc/noac174.327

ISSN: 1522-8517

Publisher: Oxford University Press